Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 672 entries
View as:

First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01323933 Org: User:
Start: 06/30/10 End: 03/31/12 Due: 03/31/13

Study of Magrolimab Given Together With FOLFIRI/BEV in Patients With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)

Phase: N/A Priority: Normal
NCT ID: NCT05330429 Org: User:
Start: 07/08/22 End: 06/26/24 Due: 06/26/25

Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT01984294 Org: User:
Start: 10/31/13 End: 07/31/14 Due: 07/31/15

GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT01434498 Org: User:
Start: 09/30/11 End: 01/31/13 Due: 01/31/14

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02607735 Org: User:
Start: 11/11/15 End: 06/21/17 Due: 06/21/18

Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00710528 Org: User:
Start: 06/30/08 End: 08/31/12 Due: 08/31/13

Fanconi Syndrome Due to ARVs in HIV-Infected Persons

Phase: N/A Priority: Normal
NCT ID: NCT00499187 Org: User:
Start: 09/30/07 End: 03/31/11 Due: 03/31/12

A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00002453 Org: User:
Start: 12/31/99 End: - Due: -

Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT04026165 Org: User:
Start: 07/24/19 End: 09/03/21 Due: 09/03/22

A Qualitative Study on Advanced Breast Cancer Patients and Their Caregivers in Spain

Phase: N/A Priority: Normal
NCT ID: NCT06683482 Org: User:
Start: 02/21/25 End: 06/30/25 Due: 06/30/26

Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT00892437 Org: User:
Start: 05/31/09 End: 01/31/15 Due: 01/31/16

Safety and Efficacy Study of 90Y-hPAM4 at Different Doses

Phase: N/A Priority: Normal
NCT ID: NCT00597129 Org: User:
Start: 08/31/04 End: 10/31/07 Due: 10/31/08

Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV)

Phase: N/A Priority: Normal
NCT ID: NCT01756482 Org: User:
Start: 11/30/12 End: 06/30/13 Due: 06/30/14

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT01590641 Org: User:
Start: 04/30/12 End: 10/31/13 Due: 10/31/14

Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients

Phase: N/A Priority: Normal
NCT ID: NCT01054729 Org: User:
Start: 01/31/10 End: 08/31/11 Due: 08/31/12

ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00879229 Org: User:
Start: 07/31/09 End: 02/28/11 Due: 02/28/12

Extension Study of Idelalisib in Participants With Chronic Lymphocytic Leukemia (CLL) Who Participated in GS-US-312-0116 (NCT01539512)

Phase: N/A Priority: Normal
NCT ID: NCT01539291 Org: User:
Start: 10/03/12 End: 06/29/18 Due: 06/29/19

Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT00832507 Org: User:
Start: 01/31/09 End: 03/31/12 Due: 03/31/13

A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT00116805 Org: User:
Start: 06/30/05 End: 01/31/16 Due: 01/31/17

Sovaldi-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT02783976 Org: User:
Start: 10/28/16 End: 06/20/18 Due: 06/20/19

Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT02246998 Org: User:
Start: 12/15/14 End: 02/17/16 Due: 02/17/17

A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis (CF)

Phase: N/A Priority: Normal
NCT ID: NCT01025713 Org: User:
Start: 12/31/09 End: 04/30/10 Due: 04/30/11

A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH)

Phase: N/A Priority: Normal
NCT ID: NCT03551522 Org: User:
Start: 04/30/18 End: 08/10/20 Due: 08/10/21

Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02545504 Org: User:
Start: 10/13/15 End: 05/15/19 Due: 05/15/20

Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT01497899 Org: User:
Start: 12/28/11 End: 08/22/16 Due: 08/22/17